Product image of Liberelle (Ethinylestradiol, Norgestimate) supplied by GNH India

Liberelle

Active Ingredient:
Ethinylestradiol, Norgestimate
Origin:
EU

Liberelle (Ethinylestradiol, Norgestimate)

Ethinylestradiol, the active ingredient in Liberelle, is a combined oral contraceptive presented as an oral tablet for oral use. It is used to prevent pregnancy and provide hormonal contraception for women of reproductive age.

GNH India supplies Liberelle as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Exeltis Poland Sp. Z O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Liberelle, a combined oral contraceptive, is used to prevent pregnancy by modulating the hormonal axis.

  • Prevention of pregnancy: provides reliable hormonal contraception for women of reproductive age.
  • Hormonal contraception: regulates menstrual cycles and reduces the risk of ovarian cyst formation.
  • Menstrual cycle regulation: helps achieve more predictable bleeding patterns.

How It Works

  • Ethinylestradiol and norgestimate act together to suppress the hypothalamic‑pituitary‑ovarian axis, inhibiting the release of luteinising hormone (LH) and follicle‑stimulating hormone (FSH). This prevents ovulation, while the progestogenic component thickens cervical mucus and alters the endometrial lining, creating an environment unsuitable for implantation.

Side Effects

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Headache: tension‑type or migraine‑like pain.
  • Breast tenderness: swelling or discomfort.
  • Weight gain: modest increase in body weight.
  • Mood changes: irritability or emotional fluctuations.
  • Spotting between periods: irregular light bleeding.

Serious or Rare Side Effects

  • Deep vein thrombosis: blood clot formation in deep veins.
  • Pulmonary embolism: clot migration to lung arteries.
  • Stroke: cerebrovascular accident due to clot or hemorrhage.
  • Myocardial infarction: heart attack risk in susceptible individuals.
  • Severe allergic reaction (anaphylaxis): rapid onset of hives, swelling, breathing difficulty.
  • Liver tumor: rare hepatic adenoma development.

Precautions & Warnings

Before starting Liberelle, consider the following precautions:

  • Contraindications: known thromboembolic disorders, cardiovascular disease, uncontrolled hypertension, estrogen‑dependent tumors, or smoking over age 35.
  • Smoking: avoid use if you are a regular smoker aged 35 or older.
  • Medication review: assess concurrent use of enzyme‑inducing drugs that may lower contraceptive efficacy.
  • Pregnancy: discontinue immediately if pregnancy is confirmed.
  • Breastfeeding: consult a healthcare provider before use during lactation.
  • Store at ambient temperature: keep below 25°C, protect from moisture and light in the original packaging.

Avoid Interactions

Liberelle may interact with several medicines. Review the following:

Major Interactions (Avoid)

  • Enzyme‑inducing antiepileptics (e.g., carbamazepine, phenytoin): reduce hormone levels and contraceptive effectiveness.
  • Rifampin: markedly decreases oral contraceptive efficacy.
  • St. John’s wort: may lower plasma concentrations of estrogen and progestin.
  • Protease inhibitors (e.g., ritonavir): can increase hormone levels, raising risk of toxicity.

Moderate Interactions (Monitor Closely)

  • Certain antibiotics (e.g., tetracycline): may slightly diminish contraceptive protection.
  • Antifungals (e.g., fluconazole): can raise hormone concentrations, requiring monitoring.
  • Diuretics (e.g., thiazides): may increase blood pressure, necessitating observation.
  • Selective serotonin reuptake inhibitors (SSRIs): may augment mood‑related side effects.

Frequently Asked Questions

Liberelle is prescribed as a combined oral contraceptive to prevent pregnancy. It provides reliable hormonal contraception for women of reproductive age and can also help regulate menstrual cycles and reduce the risk of ovarian cysts.

The two active ingredients suppress the hypothalamic‑pituitary‑ovarian axis, preventing the release of luteinising hormone and follicle‑stimulating hormone. This stops ovulation, while the progestin component thickens cervical mucus and alters the endometrium, making implantation unlikely.

The dosing regimen is determined by the prescribing clinician. Typically, patients take one tablet daily at the same time each day, but the exact schedule and duration should follow the healthcare provider’s instructions.

Liberelle is not intended for use during pregnancy and should be discontinued if pregnancy occurs. While limited data exist for breastfeeding, women should discuss potential risks and benefits with their healthcare professional before using the product while nursing.

To place an order, submit an enquiry on the Liberelle product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Liberelle contains ethinylestradiol and norgestimate, a formulation that offers a balance of estrogen and a third‑generation progestin. Compared with older progestins, norgestimate may be associated with a lower incidence of androgenic side effects such as acne, while maintaining comparable contraceptive efficacy.

Store Liberelle tablets at ambient temperature, preferably below 25 °C. Keep the blister pack in its original container, protect it from moisture and direct sunlight, and keep it out of reach of children.

Liberelle is taken orally, usually as one tablet each day. It should be swallowed with water, preferably at the same time each day, and can be taken with or without food according to the prescriber’s guidance.

Serious risks include thromboembolic events such as deep‑vein thrombosis, pulmonary embolism, stroke, and myocardial infarction. Rare but severe allergic reactions and liver tumors have also been reported. Patients should seek immediate medical attention if they experience symptoms like sudden chest pain, shortness of breath, severe headache, or unexplained swelling.

Liberelle is contraindicated in women with a history of thromboembolic disorders, uncontrolled hypertension, estrogen‑dependent tumors, active liver disease, or who are smokers over the age of 35. It should also be avoided during pregnancy and in individuals with known hypersensitivity to any component of the tablet.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ethinylestradiol, Norgestimate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT